(The H4-Index of Oncogene is 54. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer340
A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma141
Aberrant NSUN2-mediated m5C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma140
A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability134
LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression133
Targeting telomerase for cancer therapy125
High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcin125
Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations119
The functional roles of TCA cycle metabolites in cancer118
Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines112
Ferroptosis as a mechanism to mediate p53 function in tumor radiosensitivity111
Multifaceted role of branched-chain amino acid metabolism in cancer102
Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications102
Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo99
Emerging role of bacterial extracellular vesicles in cancer95
HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence94
HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression86
STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT–MET switch and cancer metastasis83
Hypoxic gastric cancer-derived exosomes promote progression and metastasis via MiR-301a-3p/PHD3/HIF-1α positive feedback loop83
Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches82
Counteracting CAR T cell dysfunction79
FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis78
Senescence as a therapeutically relevant response to CDK4/6 inhibitors77
Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis76
Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer76
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma76
The next tier of EGFR resistance mutations in lung cancer75
Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma74
RETRACTED ARTICLE: Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC172
Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy71
LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway71
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy70
Loss and revival of androgen receptor signaling in advanced prostate cancer70
RETRACTED ARTICLE: MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer69
Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP167
Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors66
NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization65
CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB164
Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance62
Partial EMT in head and neck cancer biology: a spectrum instead of a switch61
Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer60
LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1α59
Plasma exosomes from endometrial cancer patients contain LGALS3BP to promote endometrial cancer progression58
The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression57
Oncogenic functions and therapeutic targeting of EphA2 in cancer57
Nerve fibers in the tumor microenvironment in neurotropic cancer—pancreatic cancer and cholangiocarcinoma57
DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway56
The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis55
The role of MET in chemotherapy resistance55
METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m6A-YTHDF2-dependent manner54
Pathomechanisms in schwannoma development and progression54
A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination54
METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF254
Is PD-L1 a consistent biomarker for anti-PD-1 therapy? The model of balstilimab in a virally-driven tumor54